Iranian
Biomedical Journal
Volume 28, Issue 7 (Special Issue 2024)
IBJ 2024, 28(7): 199-199 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rostamani A, Hamidi-zad Z, Moslehi A, Heidari F. Role of Allantoin on the Oxidative Stress in a Mouse Model of nonalcoholic steatohepatitis. IBJ 2024; 28 (7) :199-199
URL: http://ibj.pasteur.ac.ir/article-1-4622-en.html
URL: http://ibj.pasteur.ac.ir/article-1-4622-en.html
Abstract:
Introduction: Nonalcoholic steatohepatitis (NASH) is considered a common and severe liver disease that develops into cirrhosis, fibrosis, and even hepatocellular carcinoma. Oxidative stress is identified as an important factor in the induction and promotion of NASH. Allantoin is a natural and safe compound with notable effects on lipid metabolism, inflammation, and oxidative stress. Therefore, this study aimed to assess the role of allantoin on oxidative stress in a mouse model of nonalcoholic steatohepatitis.
Methods and Materials: The C57/BL6 male mice received saline and allantoin (saline as the control and allantoin as the positive control groups). NASH was induced by a methionine-choline deficient diet (MCD). In the NASH-allantoin (NASH-Alla) group, allantoin was injected for four weeks in the mice feeding on an MCD diet. Afterward, histopathological, serum, oxidative stress, and Western blot evaluations were performed.
Results: Our results showed that NASH provided hepatic lipid accumulation and inflammation. Superoxide dismutase and glutathione (GSH) levels decreased, and lipid peroxidation increased. However, allantoin treatment decreased serum cholesterol, ALT, and AST. Liver steatosis and inflammation were improved. SOD, CAT, and GSH levels increased, and lipid peroxidation decreased.
Conclusion and Discussion: Allantoin, with rising levels of antioxidant enzymes such as GSH and lowering of lipid peroxidation, could attenuate the consequences of NASH disease. Therefore, allantoin could be considered an antioxidant and attractive candidate for NASH treatment. Future studies can help confirm this hypothesis.
Methods and Materials: The C57/BL6 male mice received saline and allantoin (saline as the control and allantoin as the positive control groups). NASH was induced by a methionine-choline deficient diet (MCD). In the NASH-allantoin (NASH-Alla) group, allantoin was injected for four weeks in the mice feeding on an MCD diet. Afterward, histopathological, serum, oxidative stress, and Western blot evaluations were performed.
Results: Our results showed that NASH provided hepatic lipid accumulation and inflammation. Superoxide dismutase and glutathione (GSH) levels decreased, and lipid peroxidation increased. However, allantoin treatment decreased serum cholesterol, ALT, and AST. Liver steatosis and inflammation were improved. SOD, CAT, and GSH levels increased, and lipid peroxidation decreased.
Conclusion and Discussion: Allantoin, with rising levels of antioxidant enzymes such as GSH and lowering of lipid peroxidation, could attenuate the consequences of NASH disease. Therefore, allantoin could be considered an antioxidant and attractive candidate for NASH treatment. Future studies can help confirm this hypothesis.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |